Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26354
Title: | Host IL-11 signaling suppresses CD4+ T cell-mediated anti-tumor responses to colon cancer in mice. | Austin Authors: | Huynh, Jennifer;Baloyan, David;Chisanga, David;Shi, Wei;O'Brien, Megan;Afshar-Sterle, Shoukat ;Alorro, Mariah;Pang, Lokman;Williams, David S ;Parslow, Adam C;Thilakasiri, Pathum;Eissmann, Moritz F ;Boon, Louis;Masson, Frederick;Chand, Ashwini L ;Ernst, Matthias | Affiliation: | Olivia Newton-John Cancer Research Institute School of Cancer Medicine at La Trobe University Olivia Newton-John Cancer Wellness and Research Centre Anatomical Pathology Bioceros, CM Utrecht University of Toulouse, CNRS, INSERM, UPS |
Issue Date: | 27-Apr-2021 | Date: | 2021-04-27 | Publication information: | Cancer immunology research 2021; 9(7): 735-747 | Abstract: | Interleukin-11 (IL-11) is a member of the IL-6 family of cytokines and signals through its cognate receptor subunits, IL11RA and glycoprotein 130 (GP130) to elicit biological responses via the JAK/STAT signaling pathway. IL-11 contributes to cancer progression by promoting the survival and proliferation of cancer cells, but the potential immunomodulatory properties of IL-11 signaling during tumor development have thus far remained unexplored. Here, we have characterized a role for IL-11 in regulating CD4+ T cell-mediated anti-tumor responses. Absence of IL-11 signaling impaired tumor growth in a sporadic mouse model of colon cancer and syngeneic allograft models of colon cancer. Adoptive bone marrow transfer experiments and in vivo depletion studies demonstrated that the tumor-promoting activity of IL-11 was mediated through its suppressive effect on host CD4+ T cells in the tumor microenvironment. Indeed, when compared to Il11ra-proficient CD4+ T cells associated with MC38 tumors, their Il11ra-deficient counterparts displayed elevated expression of mRNA encoding the anti-tumor mediators IFNγ and TNFα. Likewise, IL-11 potently suppressed the production of pro-inflammatory cytokines (IFNγ, TNFα, IL-6, and IL12p70) by CD4+ T cells in vitro, which we corroborated by RNAscope analysis of human colorectal cancers, where IL11RAhigh tumors showed less IFNG and CD4 expression than IL11RAlow tumors. Therefore, our results ascribe for a tumor-cell extrinsic immunomodulatory role for IL-11 during tumor development that is amenable to anti-cytokine based clinical management of colon cancer. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26354 | DOI: | 10.1158/2326-6066.CIR-19-1023 | ORCID: | 0000-0002-0421-3957 0000-0002-9868-6914 0000-0001-8673-1290 0000-0002-2855-0616 0000-0002-1245-729X |
Journal: | Cancer Immunology Research | PubMed URL: | 33906864 | Type: | Journal Article |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.